ArticlePediatric cardiology2026
Age-specific Association of Serum Albumin with Immunoglobulin Resistance and Coronary Artery Involvement in Kawasaki Disease.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lower albumin levels are a potential risk factor for intravenous immunoglobulin (IVIG) resistance and coronary artery lesions (CALs) in patients with Kawasaki disease (KD). No age-specific studies have been conducted on the association between lower albumin levels and these outcomes. We analyzed 18,336 patients who developed KD nationwide in Japan from 2011 to 2012. These patients were divided into three age groups: <1 year, 1–4 years, and 5–9 years. Multivariable logistic regression analyses were performed to evaluate the association between serum albumin decrease and (1) IVIG resistance and (2) CALs among these age groups. Each 0.1 g/dL albumin decrease was strongly associated with IVIG resistance in the patients aged < 1 year (adjusted odds ratios [95% confidence interval]: 1.96 [1.60–2.40]). Patients aged 1–4 years demonstrated a moderate association (1.47 [1.31–1.65]), and no association was observed in those aged 5–9 years (1.24 [0.95–1.62]). Similarly, lower albumin levels had an age-specific association with CALs (1.72 [1.11–2.70] for < 1 year, 1.67 [1.19–2.33] for 1–4 years, and 0.61 [0.33–1.10] for 5–9 years). Lower albumin levels were significantly associated with an increased risk of IVIG resistance and CALs, with the association strength varying by age. When assessing risk for treatment failure and coronary complications, serum albumin levels may be stratified by age.
Indexed as
Identifiers
41762230What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.